1 completed, 1 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
Follow capadenoson: new trials by email Literature Review of capadenoson trials Research Report on capadenoson
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Capadenoson in Angina Pectoris Capadenoson (BAY 68-4986), Placebo - Chronic Stable Angina | Phase 2 | Withdrawn | Bayer | 2008-03-01 | 2011-01-13 | |
| Study to Investigate the Effect of the A1 Agonist Capadenoson on Ventricular HR in Patients With Persistent or Permanent Atrial Fibrillation. Capadenoson (BAY68-4986) - Atrial Fibrillation | Phase 2 | Completed | Bayer | 28 | 2008-01-01 | 2014-10-29 |
Angina, Stable (1) · Atrial Fibrillation (1)
Bayer (2)
Czechia (1) · Germany (1) · Hungary (1) · Israel (1) · Italy (1) · Poland (1) · Slovakia (1)